时代
发表于 2025-3-28 18:24:23
Digital strategies in research and development (R&D)g on R&D has increased from less than 10 per cent of sales in 1970 to approximately 20 per cent in 2000 , and overall R&D spending has tripled since 1990 (Figure 5.1). The industry estimates that each approved drug must return between $300 million and $600 million to cover the cost of the failures .
2否定
发表于 2025-3-28 21:36:21
Book 2003tical guide for managers planning, developing and implementing e-strategies in the pharmaceutical industry. The authors provide numerous examples of innovative, best practice and lay the strategic foundation for using e-business across the pharmaceutical value chain from drug discovery to physician
SEEK
发表于 2025-3-29 00:27:46
http://reply.papertrans.cn/28/2798/279723/279723_43.png
白杨
发表于 2025-3-29 06:23:22
http://reply.papertrans.cn/28/2798/279723/279723_44.png
蛙鸣声
发表于 2025-3-29 10:20:23
Thomas H. Maugh II,Jean L. Marxrugs approved for use in that particular institution) and providers and payers may reach a contractual agreement with the manufacturer to allow a drug (sold at a discount) to be prescribed and reimbursed.
尊敬
发表于 2025-3-29 14:43:52
Thomas H. Maugh II,Jean L. Marxof detailing visits to physicians rose by only 15 per cent, as doctors succumbed to ‘salesperson fatigue’ . The competitive environment demands that pharmaceutical companies continue the sales force arms race in the absence of viable alternatives.
archenemy
发表于 2025-3-29 15:48:22
http://reply.papertrans.cn/28/2798/279723/279723_47.png
影响深远
发表于 2025-3-29 21:11:22
Digital strategies in pharmaceutical distributionprice of a drug may be high, it generally costs very little to produce (this is certainly changing in terms of innovative biotechnology products) and it was not generally in a manufacturer’s interest to become too deeply enmeshed in the distribution chain (Figure 7.1).
易发怒
发表于 2025-3-30 00:05:38
http://reply.papertrans.cn/28/2798/279723/279723_49.png
Cubicle
发表于 2025-3-30 05:19:43
Digital strategies in marketing to the physicianof detailing visits to physicians rose by only 15 per cent, as doctors succumbed to ‘salesperson fatigue’ . The competitive environment demands that pharmaceutical companies continue the sales force arms race in the absence of viable alternatives.